Olokizumab 64mg q4w
CL04041023
Phase 3 small_molecule completed
Quick answer
Olokizumab 64mg q4w for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at International Peace Maternity and Child Health Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- International Peace Maternity and Child Health Hospital
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed